Health
Multiple sclerosis drug may help treat COVID-19 and lead to faster recovery. – Brinkwire
What do multiple sclerosis (MS) and the novel coronavirus have in common? Until this week, not much, but a recent clinical trial has shown a reformulation of a drug used to treat MS can potentially also be used to help patients infected with COVID-19.
SNG001 is an inhaled form of a drug called interferon-beta under development by the UK pharmaceutical company Synairgen. Interferon is normally prescribed for the treatment of symptoms relating to relapsing-remitting MS.
But the clinical trial, S…
-
General13 hours agoICAC investigating University of Wollongong as chancellor grilled at Inquiry
-
General21 hours agoTwo people arrested after man fatally shot at McLaren Flat
-
General20 hours agoWarner Bros Discovery board rejects rival $163bn bid from Paramount
-
General15 hours agoOscars to move to free streaming on YouTube in 2029
